Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection

INTRODUCTION: The COVID-19 epidemic grows and there are clinical trials of antivirals. There is an opportunity to complement these trials with investigation of angiotensin II type 1 receptor blockers (ARBs) because an ARB (losartan) was effective in murine influenza pneumonia. METHODS AND ANALYSIS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, James A., Marshall, John C, Slutsky, Arthur, Murthy, Srinivas, Sweet, Dave, Lee, Terry, Singer, Joel, Patrick, David M, Du, Bin, Peng, Zhiyong, Cheng, Matthew, Burns, Kevin D, Harhay, Michael O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722825/
https://www.ncbi.nlm.nih.gov/pubmed/33293316
http://dx.doi.org/10.1136/bmjopen-2020-040768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722825/
https://www.ncbi.nlm.nih.gov/pubmed/33293316
http://dx.doi.org/10.1136/bmjopen-2020-040768

Ejemplares similares